Heart disease and stroke statistics—2022 update: a report from the American Heart Association

CW Tsao, AW Aday, ZI Almarzooq, A Alonso… - Circulation, 2022 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Heart disease and stroke statistics—2023 update: a report from the American Heart Association

CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2023 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

[HTML][HTML] Heart disease and stroke statistics-2021 update: a report from the American Heart Association.

SS Virani, A Alonso, HJ Aparicio, EJ Benjamin… - 2021 - dukespace.lib.duke.edu
Background The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Japan Atherosclerosis Society (JAS) Guidelines for prevention of atherosclerotic cardiovascular diseases 2022

T Okamura, K Tsukamoto, H Arai, Y Fujioka… - … of Atherosclerosis and …, 2024 - jstage.jst.go.jp
In Japan, a super-aged society, deaths from atherosclerotic cardiovascular disease
(ASCVD), especially cardiac diseases including coronary artery disease (CAD) such as …

[HTML][HTML] Non-genetic influences on lipoprotein (a) concentrations

B Enkhmaa, L Berglund - Atherosclerosis, 2022 - Elsevier
An elevated level of lipoprotein (a)[Lp (a)] is a genetically regulated, independent, causal
risk factor for cardiovascular disease. However, the extensive variability in Lp (a) levels …

Lipoprotein (a) and inflammation-pathophysiological links and clinical implications for cardiovascular disease

S Simantiris, AS Antonopoulos, C Papastamos… - Journal of Clinical …, 2023 - Elsevier
The role of lipoprotein (a)(Lp [a]) as a significant and possibly causal cardiovascular disease
(CVD) risk factor has been well established. Many studies, mostly experimental, have …

Long-term prognostic value of LDL-C, HDL-C, lp (a) and TG levels on cardiovascular disease incidence, by body weight status, dietary habits and lipid-lowering …

M Georgoulis, C Chrysohoou… - Lipids in Health and …, 2022 - Springer
Background The link between blood lipids and cardiovascular disease (CVD) is complex.
Our aim was to assess the differential effect of blood lipids on CVD risk according to age …

Lipoprotein (a): an update on a marker of residual risk and associated clinical manifestations

NP Shah, NJ Pajidipati, RW McGarrah… - The American journal of …, 2020 - Elsevier
Lipoprotein (a)[Lp (a)] is a low-density, cholesterol-containing lipoprotein that differs from
other low-density lipoproteins due to the presence of apolipoprotein (a) bound to its surface …

Role of increased lipoprotein (a) in retinal vein occlusion: a systematic review and meta-analysis

F Paciullo, D Giannandrea, G Virgili, C Cagini… - TH Open, 2021 - thieme-connect.com
Background Increased lipoprotein (a)[Lp (a)] has been associated with enhanced risk of
cardiovascular events and more recently with venous thromboembolism. However, there is …

[HTML][HTML] Prediction of 10-year cardiovascular disease risk by diabetes status and lipoprotein-a levels; the HellenicSCORE II+

D Panagiotakos, C Chrysohoou, C Pitsavos… - Hellenic Journal of …, 2024 - Elsevier
Background The aim of this study was to develop an updated model to predict 10-year
cardiovascular disease (CVD) risk for Greek adults, ie, the HellenicSCORE II+, based on …